It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The homeostasis of the gut epithelium relies upon continuous renewal and proliferation of crypt-resident intestinal epithelial stem cells (IESCs). Wnt/β-catenin signaling is required for IESC maintenance, however, it remains unclear how this pathway selectively governs the identity and proliferative decisions of IESCs. Here, we took advantage of knock-in mice harboring transgenic β-catenin alleles with mutations that specifically impair the recruitment of N- or C-terminal transcriptional co-factors. We show that C-terminally-recruited transcriptional co-factors of β-catenin act as all-or-nothing regulators of Wnt-target gene expression. Blocking their interactions with β-catenin rapidly induces loss of IESCs and intestinal homeostasis. Conversely, N-terminally recruited co-factors fine-tune β-catenin’s transcriptional output to ensure proper self-renewal and proliferative behaviour of IESCs. Impairment of N-terminal interactions triggers transient hyperproliferation of IESCs, eventually resulting in exhaustion of the self-renewing stem cell pool. IESC mis-differentiation, accompanied by unfolded protein response stress and immune infiltration, results in a process resembling aberrant “villisation” of intestinal crypts. Our data suggest that IESC-specific Wnt/β-catenin output requires selective modulation of gene expression by transcriptional co-factors.
How downstream regulators of Wnt/β-catenin signalling control the fate of intestinal epithelial stem cells (IESCs) is unclear. Here, the authors show that the transcriptional co-factors interacting with the N- and C-terminal domains of β-catenin differentially regulate Wnt target gene activation, in turn differentially affecting the murine IESC proliferation and differentiation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
2 University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic (GRID:grid.418827.0) (ISNI:0000 0004 0620 870X)
3 Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
4 University of Zurich, Institute of Experimental Immunology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
5 University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)